News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Binay Shah: Binaytara Foundation’s flagship conference SCHD24 is approaching
Photo taken from Binaytara Foundation/LinkedIn
Apr 25, 2024, 14:55

Binay Shah: Binaytara Foundation’s flagship conference SCHD24 is approaching

Binay Shah, President of Binaytara Foundation, shared a post by Binaytara Foundation on LinkedIn:

“This is Binaytara Foundation’s flagship conference, and I am looking forward to great discussion and improving access to cancer care in the United States and globally. Join us and interact with some of the most well-known experts in the field.”

Quoting Binaytara Foundation‘s post:

“SCHD24 is quickly approaching!

We’re excited to host one of the largest gatherings of cancer care professionals interested in cancer health disparities.
Join us on April 26th-28th”

Source: Binay Shah/LinkedIn and Binaytara Foundation/LinkedIn

 

Binay Shah Binaytara Foundation cancer cancer care professionals OncoDaily Oncology SCHD24
Special Coverage
Science
Dec 22, 2024, 10:15
Dégi László Csaba: Thrilled to announce the new Lancet Oncology Policy Review analyzing NCCPs worldwide
Science
Dec 22, 2024, 10:13
Denis Horgan: Delayed Access to Personalized Medicine in the EU - What’s the Cost to Patients?
Blog
Dec 22, 2024, 10:12
Emad Shash: Honor to be among the newly elected council of the Egyptian Cancer Society
Science
Dec 22, 2024, 10:03
María Natalia Gandur Quiroga: Checkpoint inhibitors and Fc functions - key findings in oncology immunotherapy
Science
Dec 22, 2024, 10:00
Francesco Maura: CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma
Science
Dec 22, 2024, 09:59
CDK4/6 inhibitors: mechanisms of resistance and where to find them - Lorenzo Gerratana
Blog
Dec 22, 2024, 09:53
India's Oncology Testing Market Projected to Grow at 2% CAGR Through 2033: GlobalData
Dialogues
Dec 22, 2024, 09:40
Botensilimab: A Novel Anti-CTLA- 4 Therapy Effectively Treats Refractory Colorectal Cancers
Dialogues
Dec 22, 2024, 09:04
Carlos Rodriguez-Galindo: The Man Who Will Cure the World
Science
Dec 22, 2024, 08:16
Essential Requirements for Quality Cancer Care: Ovarian - European Cancer Organisation
Science
Dec 22, 2024, 08:13
Liang Cheng: Advancements in biomarkers and molecular diagnostics in HR+ Breast Cancer
Science
Dec 22, 2024, 07:59
Ilana Schlam: The BRIDGES study is out